Abstract
Petr Kocis earned his Ph.D. in organic and medicinal chemistry at the Czechoslovak Academy of Sciences, Prague, Czechoslovakia. He did his postdoctoral research with Prof. Jack Baldwin, the University of Oxford, England and worked with the Oxford Enzyme Group. During the last two decades he has been involved in drug discovery research in cancer, immunodeficiencies, asthma and drug lead discovery at Hoechst-Marion-Roussell, Zeneca Pharmaceuticals and AstraZeneca, lately as Associate Director, Global Enabling Science & Technologies, and Principle Scientist II. Dr. Kocis is one of the pioneers of combinatorial chemistry field, he helped to build Selectides combinatorial chemistry and technology in Tucson, Arizona, in the early 90s. In the mid 90s he co-build the US Chemical Technologies group at Zeneca Pharmaceuticals and co-developed a novel combinatorial chemistry that was industrialized within the International Lead Drug Discovery as a part of modern medicinal chemistry. He is a recipient of the R & D Directors Award for Creativity and Innovation by Zeneca, and a recipient of the Henry Christian Award for Excellence in Research by Merck. He is on the editorial board of several journals including Drugs of the Future and on the Scientific Advisory Board of Cambridge Healthtech Institute. Dr. Kocis is the author or coauthor of numerous articles, book chapters and patents. His research interest is multidimensional challenges of drug discovery, modern medicinal and combinatorial chemistry, visualization and data mining.
Current Drug Discovery Technologies
Title: About Editor-in-Chief
Volume: 1 Issue: 1
Abstract: Petr Kocis earned his Ph.D. in organic and medicinal chemistry at the Czechoslovak Academy of Sciences, Prague, Czechoslovakia. He did his postdoctoral research with Prof. Jack Baldwin, the University of Oxford, England and worked with the Oxford Enzyme Group. During the last two decades he has been involved in drug discovery research in cancer, immunodeficiencies, asthma and drug lead discovery at Hoechst-Marion-Roussell, Zeneca Pharmaceuticals and AstraZeneca, lately as Associate Director, Global Enabling Science & Technologies, and Principle Scientist II. Dr. Kocis is one of the pioneers of combinatorial chemistry field, he helped to build Selectides combinatorial chemistry and technology in Tucson, Arizona, in the early 90s. In the mid 90s he co-build the US Chemical Technologies group at Zeneca Pharmaceuticals and co-developed a novel combinatorial chemistry that was industrialized within the International Lead Drug Discovery as a part of modern medicinal chemistry. He is a recipient of the R & D Directors Award for Creativity and Innovation by Zeneca, and a recipient of the Henry Christian Award for Excellence in Research by Merck. He is on the editorial board of several journals including Drugs of the Future and on the Scientific Advisory Board of Cambridge Healthtech Institute. Dr. Kocis is the author or coauthor of numerous articles, book chapters and patents. His research interest is multidimensional challenges of drug discovery, modern medicinal and combinatorial chemistry, visualization and data mining.
Export Options
About this article
Cite this article as:
About Editor-in-Chief, Current Drug Discovery Technologies 2004; 1 (1) . https://dx.doi.org/10.2174/1570163043484842
DOI https://dx.doi.org/10.2174/1570163043484842 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Metabolic Syndrome the Gynecologist’s Approach
Current Women`s Health Reviews The Clinical Relevance of Differential Cell Counts in Induced Sputum and its Relationship with Various forms of Asthma
Current Respiratory Medicine Reviews HLA-G and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Acne in the Adult
Mini-Reviews in Medicinal Chemistry Gender Differences in Chronic Cough
Current Respiratory Medicine Reviews GluVII:06 - A Highly Conserved and Selective Anchor Point for Non-Peptide Ligands in Chemokine Receptors
Current Topics in Medicinal Chemistry The Multidisciplinary Issue of Obesity: Epidemiological Studies, Company Strategies and Policy Actions: A Systematic and Methodological Review of the Research Approaches
Recent Patents on Food, Nutrition & Agriculture Phosphatidylinositol 3-Kinase Isoforms as Novel Drug Targets
Current Drug Targets Complementary and Alternative Medical Therapies in Fibromyalgia
Current Pharmaceutical Design Hypersensitivity Reactions to Ophthalmic Products
Current Pharmaceutical Design Strategies for Leukotriene Modulation in Dermatology: Even More Visionary Perspectives? An Update
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Novel Non-Steroidal Anti-Inflammatory Drugs: What we have Learned from Animal Studies
Current Drug Targets - Inflammation & Allergy Natural Resins and Bioactive Natural Products thereof as Potential Anitimicrobial Agents
Current Pharmaceutical Design Chemokines and their Receptors in Gut Homeostasis and Disease
Current Immunology Reviews (Discontinued) Development and Validation of UHPLC/ESI-Q-TOF-MS Method for Terbutaline Estimations in Experimental Rodents: Stability Effects and Plasma Pharmacokinetics
Current Pharmaceutical Analysis Medicinal Plant <i>Centipeda Minima</i>: A Resource of Bioactive Compounds
Mini-Reviews in Medicinal Chemistry Drug Repositioning: A Unique Approach to Refurbish Drug Discovery
Current Drug Discovery Technologies Screening of Anti-Histaminic Activity of Fagonia Schweinfurthii Hadidi in Guinea Pig Ileum and Formulate Anti-Histaminic Syrup
The Natural Products Journal Cholestasis During Pregnancy: Aetiopathogenesis, Foetal-Maternal Repercussions and Pharmacological Treatments
Current Women`s Health Reviews Free Radicals and Oxidative Stress: Signaling Mechanisms, Redox Basis for Human Diseases, and Cell Cycle Regulation
Current Molecular Medicine